Literature DB >> 23934543

Role of maca (Lepidium meyenii) consumption on serum interleukin-6 levels and health status in populations living in the Peruvian Central Andes over 4000 m of altitude.

Gustavo F Gonzales1, Manuel Gasco, Ivan Lozada-Requena.   

Abstract

Lepidium meyenii (Maca) is a plant that grows at over 4,000 m above sea level in the central Peruvian Andes. The hypocotyls of this plant are traditionally consumed for their nutritional and medicinal properties. The aim of this study was to determine the health status based on a health related quality of life (HRQL) questionnaire (SF-20) and serum levels of interleukin 6 (IL-6) in subjects that are maca consumers. For this, a cross-sectional study was designed to be performed in 50 subjects from Junin (4,100 m): 27 subjects were maca consumers and 23 were non-consumers. The SF-20 survey is used to obtain a summary measure of health status. The stand up from a chair and sit down (SUCSD) test (to assess lower-extremity function), hemoglobin measurement, blood pressure, sexual hormone levels, serum IL-6 levels and the score of chronic mountain sickness (CMS) were evaluated. Testosterone/estradiol ratio (P <0.05), IL-6 (P < 0.05) and CMS score were lower, whereas the health status score was higher, in maca consumers when compared to non-consumers (P < 0.01). A greater proportion of maca consumers successfully completed the SUCSD test compared to non-consumers (P < 0.01), showing a significant association with lower values of serum IL-6 (P < 0.05). In conclusion, consumption of maca was associated with low serum IL-6 levels and in turn with better health status scores in the SF-20 survey and low chronic mountain sickness scores.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23934543      PMCID: PMC3856628          DOI: 10.1007/s11130-013-0378-5

Source DB:  PubMed          Journal:  Plant Foods Hum Nutr        ISSN: 0921-9668            Impact factor:   3.921


  38 in total

1.  High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein.

Authors:  G Hartmann; M Tschöp; R Fischer; C Bidlingmaier; R Riepl; K Tschöp; H Hautmann; S Endres; M Toepfer
Journal:  Cytokine       Date:  2000-03       Impact factor: 3.861

2.  Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars.

Authors:  Nancy S Jenny; Benjamin French; Alice M Arnold; Elsa S Strotmeyer; Mary Cushman; Paulo H M Chaves; Jingzhong Ding; Linda P Fried; Stephen B Kritchevsky; Dena E Rifkin; Mark J Sarnak; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-24       Impact factor: 6.053

3.  Effects of strength and flexibility training on functional performance of healthy older people.

Authors:  Rafaella R Locks; Tatiana C Costa; Soraia Koppe; Anelize M Yamaguti; Maurício C Garcia; Anna R S Gomes
Journal:  Rev Bras Fisioter       Date:  2012-06

4.  Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso Longeva--TRELONG).

Authors:  Diego Albani; Stefano Mazzuco; Letizia Polito; Sara Batelli; Gloria Biella; Fausta Ongaro; Deborah R Gustafson; Piero Antuono; Gianbattista Gajo; Elisabetta Durante; Livio Caberlotto; Andrea Zanardo; Marinella Siculi; Maurizio Gallucci; Gianluigi Forloni
Journal:  Aging Male       Date:  2011-12       Impact factor: 5.892

5.  Population differences in proinflammatory biology: Japanese have healthier profiles than Americans.

Authors:  Christopher L Coe; Gayle D Love; Mayumi Karasawa; Norito Kawakami; Shinobu Kitayama; Hazel R Markus; Russell P Tracy; Carol D Ryff
Journal:  Brain Behav Immun       Date:  2010-11-26       Impact factor: 7.217

6.  Day-to-day variation in plasma interleukin-6 concentrations in older adults.

Authors:  Mindi Picotte; Christina Gayer Campbell; William G Thorland
Journal:  Cytokine       Date:  2009-07-14       Impact factor: 3.861

7.  Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial.

Authors:  T Zenico; A F G Cicero; L Valmorri; M Mercuriali; E Bercovich
Journal:  Andrologia       Date:  2009-04       Impact factor: 2.775

8.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Authors:  Daniel I Swerdlow; Michael V Holmes; Karoline B Kuchenbaecker; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Yiran Guo; Christina Chung; Anne Peasey; Roman Pfister; Simon P Mooijaart; Helen A Ireland; Maarten Leusink; Claudia Langenberg; Ka Wah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; John Hardy; Michael A Nalls; Yun Rose Li; Gordon Lowe; Marlene Stewart; Suzette J Bielinski; Julian Peto; Nicholas J Timpson; John Gallacher; Malcolm Dunlop; Richard Houlston; Ian Tomlinson; Ioanna Tzoulaki; Jian'an Luan; Jolanda M A Boer; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Luigi Ferrucci; Stefania Bandenelli; Toshiko Tanaka; James F Meschia; Andrew Singleton; Gerjan Navis; Irene Mateo Leach; Stephan J L Bakker; Ron T Gansevoort; Ian Ford; Stephen E Epstein; Mary Susan Burnett; Joe M Devaney; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Yolanda van der Graaf; Pim A de Jong; Anke-Hilse Mailand-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Jeffrey W Stephens; Charles B Eaton; Jennifer G Robinson; JoAnn E Manson; F Gerry Fowkes; Timonthy M Frayling; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Susan Redline; Leslie A Lange; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Emelia J Benjamin; John C Whittaker; Anders Hamsten; Frank Dudbridge; J A Chris Delaney; Andrew Wong; Diana Kuh; Rebecca Hardy; Berta Almoguera Castillo; John J Connolly; Pim van der Harst; Eric J Brunner; Michael G Marmot; Christina L Wassel; Steve E Humphries; Philippa J Talmud; Mika Kivimaki; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Hakon Hakonarson; Alex P Reiner; Brendan J Keating; Naveed Sattar; Aroon D Hingorani; Juan Pablo Casas
Journal:  Lancet       Date:  2012-03-14       Impact factor: 79.321

9.  The influence of maca (Lepidium meyenii) on antioxidant status, lipid and glucose metabolism in rat.

Authors:  Rostislav Vecera; Jan Orolin; Nina Skottová; Ludmila Kazdová; Olena Oliyarnik; Jitka Ulrichová; Vilím Simánek
Journal:  Plant Foods Hum Nutr       Date:  2007-06       Impact factor: 4.124

10.  Aqueous Extract of Black Maca (Lepidium meyenii) on Memory Impairment Induced by Ovariectomy in Mice.

Authors:  Julio Rubio; Wang Qiong; Xinmin Liu; Zhen Jiang; Haixia Dang; Shi-Lin Chen; Gustavo F Gonzales
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

View more
  4 in total

1.  Lepidium meyenii Walp (red maca) Supplementation Prevents Acrylamide-Induced Oxidative Stress and Liver Toxicity in Rats: Phytochemical Composition by UHPLC-ESI-MS/MS.

Authors:  Roberto O Ybañez-Julca; Javier Palacios; Daniel Asunción-Alvarez; Ivan Quispe-Díaz; Chukwuemeka R Nwokocha; Ricardo Diego Duarte Galhardo de Albuquerque
Journal:  Plant Foods Hum Nutr       Date:  2022-08-06       Impact factor: 4.124

2.  Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Carla Gonzales-Arimborgo; Irma Yupanqui; Elsa Montero; Dulce E Alarcón-Yaquetto; Alisson Zevallos-Concha; Lidia Caballero; Manuel Gasco; Jianping Zhao; Ikhlas A Khan; Gustavo F Gonzales
Journal:  Pharmaceuticals (Basel)       Date:  2016-08-18

Review 3.  The Potential Role of Nutraceuticals as an Adjuvant in Breast Cancer Patients to Prevent Hair Loss Induced by Endocrine Therapy.

Authors:  Giorgio Dell'Acqua; Aleksander Richards; M Julie Thornton
Journal:  Nutrients       Date:  2020-11-18       Impact factor: 5.717

4.  Protective role of estrogen against excessive erythrocytosis in Monge's disease.

Authors:  Priti Azad; Francisco C Villafuerte; Daniela Bermudez; Gargi Patel; Gabriel G Haddad
Journal:  Exp Mol Med       Date:  2021-01-20       Impact factor: 8.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.